Newsroom - Page 3

The Kaiser Family Foundation Health Tracking Poll periodically gauges public opinion on important health issues. It found 56% of Americans had some connection to the painkiller epidemic and 16% knew someone who had died.
What we're reading, November 24, 2015: expensive hepatitis C drugs are more cost effective when used earlier; clinicians aren't prescribing generics enough; and half of health 45-year-olds will develop prediabetes.
The approval follows 5 months after Bristol-Myers Squibb submitted phase 3 results of the Checkmate-066 trial for FDA review.
Terms of the deal with the second-largest pharmacy benefit manager were not disclosed. Pricing for the PCSK9 inhibitor class has been a source of controversy since the cholesterol-fighting drugs were approved this summer.
Community-based organizations are ideally suited for healthcare prevention efforts and provide a needed linkage to medical care provider systems.
Two months after being granted a Breakthrough Therapy designation by the FDA for metastatic renal cell carcinoma (mRCC), nivolumab was today approved by regulators for treating mRCC patients who have failed a certain type of prior therapy.
Workers give low marks to the US healthcare system based primarily on cost, but rate their own plans favorably.
The study credited better drugs and improvements in foot inspections and self-care with the reduction.
Diabetes Compendium
Oncology Compendium